vs
Digimarc CORP（DMRC）与Wave Life Sciences Ltd.（WVE）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是Wave Life Sciences Ltd.的1.0倍（$8.9M vs $8.7M），Digimarc CORP净利率更高（-47.2% vs -580.2%，领先532.9%），Digimarc CORP同比增速更快（2.9% vs -55.8%），Digimarc CORP自由现金流更多（$895.0K vs $-46.3M），过去两年Digimarc CORP的营收复合增速更高（-5.3% vs -18.0%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
BIT生命科学是总部位于中国大连的会展(MICE)企业，主营学术会议筹办，旗下举办的多场科学会议被界定为“掠夺性”会议。这类近年在国内涌现的机构筹办的会议学术价值极低，核心目的是盈利，而非促进学术知识交流，投稿的论文通常缺乏严格的学术审核。
DMRC vs WVE — 直观对比
营收规模更大
DMRC
是对方的1.0倍
$8.7M
营收增速更快
DMRC
高出58.7%
-55.8%
净利率更高
DMRC
高出532.9%
-580.2%
自由现金流更多
DMRC
多$47.2M
$-46.3M
两年增速更快
DMRC
近两年复合增速
-18.0%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $8.7M |
| 净利润 | $-4.2M | $-50.5M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -606.5% |
| 净利率 | -47.2% | -580.2% |
| 营收同比 | 2.9% | -55.8% |
| 净利润同比 | 51.4% | -53.3% |
| 每股收益（稀释后） | $-0.18 | $-0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCWVE
| Q4 25 | $8.9M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $8.0M | $8.7M | ||
| Q1 25 | $9.4M | $9.2M | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.4M | $19.7M | ||
| Q1 24 | $9.9M | $12.5M |
净利润DMRCWVE
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | — | ||
| Q2 25 | $-8.2M | $-50.5M | ||
| Q1 25 | $-11.7M | $-46.9M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | — | ||
| Q2 24 | $-9.3M | $-32.9M | ||
| Q1 24 | $-10.3M | $-31.6M |
毛利率DMRCWVE
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCWVE
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | — | ||
| Q2 25 | -105.2% | -606.5% | ||
| Q1 25 | -128.9% | -542.8% | ||
| Q4 24 | -105.1% | — | ||
| Q3 24 | -120.4% | — | ||
| Q2 24 | -96.2% | -177.7% | ||
| Q1 24 | -109.2% | -274.8% |
净利率DMRCWVE
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | — | ||
| Q2 25 | -102.6% | -580.2% | ||
| Q1 25 | -125.2% | -510.9% | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | — | ||
| Q2 24 | -89.3% | -167.2% | ||
| Q1 24 | -104.0% | -251.7% |
每股收益（稀释后）DMRCWVE
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | — | ||
| Q2 25 | $-0.38 | $-0.31 | ||
| Q1 25 | $-0.55 | $-0.29 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.50 | — | ||
| Q2 24 | $-0.43 | $-0.25 | ||
| Q1 24 | $-0.50 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $208.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $139.3M |
| 总资产 | $53.0M | $252.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCWVE
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $16.1M | $208.5M | ||
| Q1 25 | $21.6M | $243.1M | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $33.7M | — | ||
| Q2 24 | $41.5M | $154.0M | ||
| Q1 24 | $48.9M | $180.9M |
股东权益DMRCWVE
| Q4 25 | $40.2M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $46.5M | $139.3M | ||
| Q1 25 | $50.0M | $171.8M | ||
| Q4 24 | $61.4M | — | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $77.2M | $-3.5M | ||
| Q1 24 | $84.5M | $25.4M |
总资产DMRCWVE
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.4M | — | ||
| Q2 25 | $60.7M | $252.4M | ||
| Q1 25 | $66.5M | $288.3M | ||
| Q4 24 | $75.8M | — | ||
| Q3 24 | $85.0M | — | ||
| Q2 24 | $93.4M | $208.8M | ||
| Q1 24 | $99.7M | $235.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-46.0M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-46.3M |
| 自由现金流率自由现金流/营收 | 10.0% | -532.5% |
| 资本支出强度资本支出/营收 | 1.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-170.9M |
8季度趋势，按日历期对齐
经营现金流DMRCWVE
| Q4 25 | $991.0K | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | $-4.7M | $-46.0M | ||
| Q1 25 | $-5.5M | $-63.0M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.1M | — | ||
| Q2 24 | $-6.8M | $-27.5M | ||
| Q1 24 | $-8.4M | $-33.4M |
自由现金流DMRCWVE
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | $-46.3M | ||
| Q1 25 | $-5.5M | $-63.2M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | $-27.5M | ||
| Q1 24 | $-8.5M | $-33.8M |
自由现金流率DMRCWVE
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | -532.5% | ||
| Q1 25 | -59.1% | -688.9% | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | -139.8% | ||
| Q1 24 | -85.8% | -270.0% |
资本支出强度DMRCWVE
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | 3.5% | ||
| Q1 25 | 0.6% | 1.8% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | 0.3% | ||
| Q1 24 | 1.1% | 3.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
WVE
暂无分部数据
